UK Extends Recognition Of EU Batch Testing Pending Review
Industry Welcomes ‘Pragmatic’ Move
Having to set up duplicate testing facilities in the EU and the UK is an expensive business, so pharmaceutical companies are relieved that the UK is giving them some extra breathing space.
You may also be interested in...
The UK BioIndustry Association says the updated guidance will result in duplicative and costly repetition and dent industry’s confidence in the government’s competence.
An explicit ban on patent linkage would ensure that competition to originator drugs is not delayed, according to off-patent industry group Medicines for Europe.
Members of the European Parliament have ignored pleas from the EPP political group and the German Federal Council to drop a proposal allowing third parties to oppose the granting of a supplementary protection certificate.